Meta‐analysis of first‐line therapies with maintenance regimens for advanced non‐small‐cell lung cancer (NSCLC) in molecularly and clinically selected populations

Evidence has suggested survival benefits of maintenance for advanced NSCLC patients not progressing after first‐line chemotherapy. Additionally, particular first‐line targeted therapies have shown survival improvements in selected populations. Optimal first‐line and maintenance therapies remain uncl...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Pui San, Bilger, Marcel, de Lima Lopes, Gilberto, Acharyya, Sanchalika, Haaland, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548880/
https://www.ncbi.nlm.nih.gov/pubmed/28675660
http://dx.doi.org/10.1002/cam4.1101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548880/
https://www.ncbi.nlm.nih.gov/pubmed/28675660
http://dx.doi.org/10.1002/cam4.1101

Ejemplares similares